81, Irwon- Ro
Gangnam-gu
Seoul, 135-710
Korea, Republic of (South Korea)
HR-positive, HER2-negative metastatic breast cancer; premenopausal women; palbociclib, exemestance, capecitabine
Non-small cell lung cancer; tumor mutation burden, immunotherapy, Homologous recombination deficiency, STING pathway